プロモーションスケジュール Agentix Corp
詳細なスケジュール
簡易グラフ
会社について Agentix Corp
Agentix Corp., a clinical development stage company, focuses on the development and commercialization of novel therapeutics to treat metabolic diseases in the United States. The company offers AGTX-2004, a peripherally-acting CB1 receptor antagonist that has demonstrated efficacy in animal models of obesity and type 2 diabetes mellitus; and AGTX-2003, a peripherally-acting CB1 receptor inverse agonist, which has demonstrated efficacy in animal models of obesity and non-alcoholic fatty liver diseases. The company was formerly known as FairWind Energy, Inc. and changed its name to Agentix Corp. さらに詳しく| ISIN | US00848A1034 |
|---|---|
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Сайт | https://www.agentixcorp.com |
| Цена ао | 0.0811 |
| 1日あたりの価格変動: | +1.11% (0.0811) |
|---|---|
| 週ごとの価格変動: | +1.11% (0.0811) |
| 月ごとの料金変更: | -25.59% (0.1102) |
| 3ヶ月間の価格変動: | -65.83% (0.24) |
| 半年間の価格変動: | +203.7% (0.027) |
| 年間の価格変動: | +64% (0.05) |
| 3年間の価格推移: | -90.11% (0.829) |
| 5年間の価格推移: | -99.66% (24) |
| 10年間の価格推移: | +0% (0.082) |
| 年初からの価格変動: | -48.78% (0.1601) |
|
|
過小評価
|
効率
|
|||||||||||||||||||||||||||||||||||||
配当金
|
義務
|
成長の衝動
|
|||||||||||||||||||||||||||||||||||||
| スーパーバイザー | 役職 | 支払い | 生年 |
|---|---|---|---|
| Martin Schroeder | Chief Scientific Officer & Member of Scientific Advisory Board |
住所: United States, Dana Point, 32932 Pacific Coast Highway - Googleマップで開く, Yandexマップを開く
Webサイト: https://www.agentixcorp.com
Webサイト: https://www.agentixcorp.com
